Glob Cardiol Sci Pract
Department of Internal Medicine, Jefferson Abington Hospital Abington PA.
Published: December 2024
Among viral myocarditis, human metapneumovirus (hMPV) is a rare causative agent with associated cardiac complications. This report provides insight into the disease progression and sheds light on reported cases from the literature. We present the clinical courses of two patients, aged 68 and 58, who developed myocarditis secondary to hMPV infection. Despite the typical severity associated with viral myocarditis in older populations, both patients experienced significant improvement in their condition and ultimately survived. This report highlights the necessity of recognizing hMPV as a potential cause of myocarditis, particularly in older adults presenting with simultaneous respiratory and cardiac symptoms. The recovery and survival of these patients underscore the critical need for awareness and timely treatment strategies to manage this potentially severe condition.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11871563 | PMC |
http://dx.doi.org/10.21542/gcsp.2024.52 | DOI Listing |
Bone Marrow Transplant
March 2025
Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, Mexico.
Autologous hematopoietic cell transplantation (aHSCT) is a viable therapeutic approach in patients with autoimmune diseases. Since June 2015, we have autografted on an outpatient basis 1700 aHSCT patients. The objective was to analyze the salient features of early post-aHSCT complications when performed in the outpatient setting.
View Article and Find Full Text PDFEur Heart J Case Rep
March 2025
Department of Cardiology, Antwerp University Hospital, Drie Eikenstraat 655, 2650 Edegem, Belgium.
Background: Disseminated infection is a severe condition in immunocompromised patients. Mortality secondary to cardiac infection remains high.
Case Summary: We present a case of a 45-year-old female breast cancer patient who developed endocarditis and myocarditis after receiving the immune checkpoint inhibitor (ICI) pembrolizumab.
Glob Cardiol Sci Pract
December 2024
Department of Internal Medicine, Jefferson Abington Hospital Abington PA.
Among viral myocarditis, human metapneumovirus (hMPV) is a rare causative agent with associated cardiac complications. This report provides insight into the disease progression and sheds light on reported cases from the literature. We present the clinical courses of two patients, aged 68 and 58, who developed myocarditis secondary to hMPV infection.
View Article and Find Full Text PDFEur Heart J Suppl
February 2025
De Gasperis Cardio Center, Niguarda Hospital, Piazza Ospedale Maggiore 3, 20162 Milan, Italy.
Acute myocarditis (AM) is an inflammatory injury of the myocardium secondary to infections, systemic autoimmune disorders, medications, or toxic agents. The patient's genetic underground is a likely concurrent aetiology/contributory mechanism recently implicated in a proportion of AM. This review focuses on some critical new concepts of AM, updated indications for endomyocardial biopsy when cardiac magnetic resonance imaging is not sufficient or feasible, and estimation of long-term events after discharge.
View Article and Find Full Text PDFBackground: A viral vector recombinant gene transfer therapy (GTT) has recently been approved by the FDA for males of all ages with Duchenne Muscular Dystrophy (DMD) without limitations regarding preexisting cardiac impairment. Acute myocarditis is a potential life-threatening short-term complication that has been reported following GTT. This immune mediated response can range from troponin elevation to rapid cardiovascular compromise and death, particularly in those with abnormal cardiac status at baseline.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!
© LitMetric 2025. All rights reserved.